Tinea Corporis Market Latest Trends, Regional Outlook and COVID-19 Impact Analysis 2027

08/apr/2021 17:47:57 Market Research Future Contatta l'autore

Global Tinea Corporis Market is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.

Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi. This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body.

The global tinea corporis market is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.

Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person.

Top Industry Key players:

Some of the key players in the global tinea corporis market are

  • Taro Pharmaceuticals. Inc.
  • Teva Pharmaceuticals Inc.
  • Glenmark Pharmaceuticals Inc
  • Breckenridge Pharmaceutical Inc.
  • NorthStar Rx LLC
  • Aurobindo Pharma Limited
  • and Camber Pharmaceuticals Inc.
  • AvKare Inc.
  • Novartis AG
  • Sebela Pharmaceuticals Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd
  • Perrigo Company.

Market Segmentation:

Global tinea corporis market is segmented into drug type, diagnosis, treatment and end-users.

Global Tinea Corporis Market by Drug Type

  • Antifungals
  • Steroids
  • Anti-Infective Combinations

Global Tinea Corporis Market, by Diagnosis

  • Physical Exam
  • Imaging Tests
    • Wood lamp (black light) examination
    • Microscopy using potassium hydroxide (KOH)
    • Fungal culture
    • Skin biopsy
    • Others

Global Tinea Corporis Market, by Treatment

  • Antifungal shampoos
  • Antifungal creams
  • Drugs
  • Others

Global Tinea Corporis Market, by End-Users

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Dermatology hospitals
  • Others

Regional Market Summary

Geographically, the America holds the highest market share for tinea corporis market and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region

Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.

Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.

Intended Audience

  • Manufacturers and Suppliers
  • Hospitals and Clinics
  • Laboratories and Associations
  • Research Institutes
  • Dermatology Clinics

Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838

 

 

About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

blog comments powered by Disqus
Comunicati.net รจ un servizio offerto da Factotum Srl